(-0.11%) 5 463.51 points
(0.07%) 39 139 points
(0.07%) 17 731 points
(-0.04%) $80.80
(-5.04%) $2.62
(-0.85%) $2 311.10
(-0.25%) $28.80
(3.19%) $1 017.90
(0.35%) $0.936
(0.76%) $10.68
(0.54%) $0.792
(-0.27%) $87.25
0.00% $ 0.0701
Live Chart Being Loaded With Signals
PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel for cardiovascular diseases...
Stats | |
---|---|
Volumen de hoy | 8.56M |
Volumen promedio | 0 |
Capitalización de mercado | 0.00 |
EPS | $-0.340 ( Q2 | 2022-08-12 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0300 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0750 (106.99%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-05-19 | Van Den Broek Richard | Buy | 3 750 | Common Stock |
2023-05-19 | Van Den Broek Richard | Sell | 3 750 | Restricted Stock Units |
2023-05-19 | Thorp Clay | Buy | 3 750 | Common Stock |
2023-05-19 | Thorp Clay | Buy | 3 750 | Restricted Stock Units |
2023-05-19 | Humphries William D. | Buy | 2 538 | Common Stock |
INSIDER POWER |
---|
-91.57 |
Last 98 transactions |
Buy: 2 306 852 | Sell: 1 915 751 |
Volumen Correlación
PhaseBio Pharmaceuticals, Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
PhaseBio Pharmaceuticals, Correlación - Moneda/Commodity
PhaseBio Pharmaceuticals, Finanzas
Annual | 2021 |
Ingresos: | $10 831.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.00446 |
FY | 2021 |
Ingresos: | $10 831.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.00446 |
FY | 2020 |
Ingresos: | $320 000 |
Beneficio Bruto: | $320.00 (0.10 %) |
EPS: | $-3.39 |
FY | 2019 |
Ingresos: | $2.36M |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-1.430 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
PhaseBio Pharmaceuticals,
PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel for cardiovascular diseases. Its lead product candidate is bentracimab (PB2452), a reversal agent for the antiplatelet drug ticagrelor that is in Phase III clinical trial for patients with uncontrolled major or life-threatening bleeding events or in patients requiring urgent or an invasive procedure. The company is also developing PB1046, a vasoactive intestinal peptide analogue for the treatment of pulmonary arterial hypertension; and PB6440 for the treatment of resistant hypertension. The company has a co-development agreement with SFJ Pharmaceuticals X, Ltd. to develop PB2452, a reversal agent for the antiplatelet drug ticagrelor. PhaseBio Pharmaceuticals, Inc. was incorporated in 2002 and is based in Malvern, Pennsylvania. On October 23, 2022, PhaseBio Pharmaceuticals, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico